# Phase I Clinical Study Evaluating the Relative Bioavailability of Different Formulations of HRS-5346 in Healthy Participants

> **NCT07752069** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Shandong Suncadia Medicine Co., Ltd.** · enrollment: 50 (estimated)

## Conditions studied

- Lipoprotein Disorder

## Interventions

- **DRUG:** HRS-5346
- **DRUG:** HRS-5346

## Key facts

- **NCT ID:** NCT07752069
- **Lead sponsor:** Shandong Suncadia Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08
- **Primary completion:** 2026-09
- **Final completion:** 2026-10
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07752069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07752069, "Phase I Clinical Study Evaluating the Relative Bioavailability of Different Formulations of HRS-5346 in Healthy Participants". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07752069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*